Affordability is tied to quality Viveka Roychowdhury Aug 17, 2023 In a freewheeling conversation, Leena Menghaney, Regional Head, MSF Access Campaign explains to Viveka Roychowdhury how the Covid…
China approves its first mRNA vaccine from CSPC Reuters Mar 23, 2023 The company said its independently developed mRNA vaccine SYS6006 targets some major Omicron variants and its booster dose showed…
Chinese regulators focus on homegrown COVID-19 therapies to tackle new variants: GlobalData EP News Bureau Feb 21, 2023 There are currently 16 COVID-19 drugs in clinical development in China, five of which are in Phase III. Most of these drugs in the…
Rising costs forced patients to postpone or stop treatments in 2022: GlobalData EP News Bureau Feb 14, 2023 Compared to other researched markets (France, Germany, Italy, Spain, the UK and Japan), the US respondents reported the highest…
Paxlovid decreased hospitalisation, risk of death during Omicron wave: Research PTI Feb 13, 2023 The research, published in the Canadian Medical Association Journal, aimed to evaluate the effectiveness of paxlovid, a…
The (pharma) sector is learning to create capabilities in innovative R&D rapidly Lakshmipriya Nair Feb 11, 2023 Dr Sanjay Kumar Jain, President - India Operations, Amneal Pharmaceuticals speaks about the emerging trends in pharma R&D,…
Covid vaccines do not increase risk of adverse events: Study PTI Feb 11, 2023 The study is currently the only one in the world that monitored the population for more than a year, taking into account numerous…
Hetero’s ‘NIRMACOM’ gets WHO Prequalification for COVID-19 treatment EP News Bureau Dec 26, 2022 Hetero’s ‘NIRMACOM’ (Nirmatrelvir), a generic version of Pfizer’s COVID-19 oral antiviral drug ‘PAXLOVID’is co-packaged with…
CORBEVAX gets EUA from Health Ministry as heterologous COVID-19 booster shot for 18 years and above EP News Bureau Aug 11, 2022 CORBEVAX is expected to be available as a Booster dose on the CoWIN App in public and private vaccination centres from August 12,…
GSK, IQVIA launch Vaccine Track, a data trend platform to improve adult vaccination in US EP News Bureau Aug 11, 2022 Vaccine Track data insights revealed sustained decline of recommended adult immunisations, excluding flu vaccinations, across the…